The relationship between hypoxia and angiogenesis

Seminars in Radiation Oncology

Volumn 14, Issue 3, 2004, Pages 215-221

  Moeller, Benjamin J ^b   Cao, Yiting ^b   Vujaskovic, Zeljko ^b   Li, Chuan Y ^b   Haroon, Zishan A ^b   Dewhirst, Mark W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CARCINOGENESIS; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HYPOXIA; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE OXYGENATION; WOUND HEALING;

EID: 3142628260     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2004.04.005     Document Type: Article

References (50)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med. 9:2003;653-660
2. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 29:2002;15-18
3. Beasley N.J., Wykoff C.C., Watson P.H., et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res. 61:2001;5262-5267
4. Mattern J., Kallinowski F., Herfarth C., et al. Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer. 67:1996;20-23
5. Birner P., Piribauer M., Fischer I., et al. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins Evidence for distinct angiogenic subtypes. Brain Pathol. 13:2003;133-143
6. Raleigh J.A., Calkins-Adams D.P., Rinker L.H., et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res. 58:1998;3765-3768
7. Vordermark D., Brown J.M. Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma In vitro and xenograft studies. Int J Radiat Oncol Biol Phys. 56:2003;1184-1193
8. Vukovic V., Haugland H.K., Nicklee T., et al. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res. 61:2001;7394-7398
9. Danielsen T., Rofstad E.K. The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts. Br J Cancer. 82:2000;1528-1534
10. Choi D.W. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol. 6:1996;667-672
11. Jennings R.B., Reimer K.A. The cell biology of acute myocardial ischemia. Annu Rev Med. 42:1991;225-246
12. Ninikoski J., Heughan C., Hunt T.K. Oxygen and carbon dioxide tensions in experimental wounds. Surg Gynecol Obstet. 133:1971;1003-1007
13. Goodson W.H. 3rd, Andrews W.S., Thakral K.K., et al. Wound oxygen tension of large vs small wounds in man. Surg Forum. 30:1979;92-95
14. Knighton D.R., Silver I.A., Hunt T.K. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery. 90:1981;262-270
15. Sakuda H., Nakashima Y., Kuriyama S., et al. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1. Am J Pathol. 141:1992;1507-1516
16. Shweiki D., Itin A., Soffer D., et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845
17. Albina J.E., Mastrofrancesco B., Vessella J.A., et al. HIF-1 expression in healing wounds HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol. 281:2001;C1971-1977
18. Nissen N.N., Polverini P.J., Koch A.E., et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol. 152:1998;1445-1452
19. Chang N., Goodson W.H. 3rd, Gottrup F., et al. Direct measurement of wound and tissue oxygen tension in postoperative patients. Ann Surg. 197:1983;470-478
20. Haroon Z.A., Raleigh J.A., Greenberg C.S., et al. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg. 231:2000;137-147
21. Alarcon R.M., Denko N.C., Giaccia A.J. Genetic determinants that influence hypoxia-induced apoptosis. Novartis Found Symp. 240:2001;115-128. discussion 128-132
22. Graeber T.G., Osmanian C., Jacks T., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:1996;88-91
23. Anderson B., Saltzman H. Retinal oxygen utilization measured by hyperbaric blackout. Arch Ophthalmol. 72:1964;792-795
24. Hogeboom van Buggenum I.M., van der Heijde G.L., Tangelder G.J., et al. Ocular oxygen measurement. Br J Ophthalmol. 80:1996;567-573
25. Frayser R., Gray G.W., Houston C.S. Control of the retinal circulation at altitude. J Appl Physiol. 37:1974;302-304
26. Wilson C.A., Berkowitz B.A., McCuen B.W. 2nd, et al. Measurement of preretinal oxygen tension in the vitrectomized human eye using fluorine-19 magnetic resonance spectroscopy. Arch Ophthalmol. 110:1992;1098-1100
27. Hale L.P., Braun R.D., Gwinn W.M., et al. Hypoxia in the thymus Role of oxygen tension in thymocyte survival. Am J Physiol Heart Circ Physiol. 282:2002;H1467-H1477
28. Braun R.D., Lanzen J.L., Snyder S.A., et al. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am J Physiol Heart Circ Physiol. 280:2001;H2533-H2544
29. Moss A.J. Intramyocardial oxygen tension. Cardiovasc Res. 2:1968;314-318
30. Padnick L.B., Linsenmeier R.A., Goldstick T.K. Oxygenation of the cat primary visual cortex. J Appl Physiol. 86:1999;1490-1496
31. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 3:2003;721-732
32. Spranger J., Pfeiffer A.F. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes. 109:(suppl 2):2001;S438-450
33. Freyer J.P., Sutherland R.M. A reduction in the in situ rates of oxygen and glucose consumption of cells in EMT6/Ro spheroids during growth. J Cell Physiol. 124:1985;516-524
34. Freyer J.P. Rates of oxygen consumption for proliferating and quiescent cells isolated from multicellular tumor spheroids. Adv Exp Med Biol. 345:1994;335-342
35. Li C.Y., Shan S., Huang Q., et al. Initial stages of tumor cell-induced angiogenesis Evaluation via skin window chambers in rodent models. J Natl Cancer Inst. 92:2000;143-147
36. Secomb T.W., Hsu R., Braun R.D., et al. Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv Exp Med Biol. 454:1998;629-634
37. Secomb T.W., Hsu R., Ong E.T., et al. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol. 34:1995;313-316
38. Leek R.D., Lewis C.E., Whitehouse R., et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56:1996;4625-4629
39. Fujimoto J., Sakaguchi H., Aoki I., et al. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res. 60:2000;2632-2635
40. Lissbrant I.F., Stattin P., Wikstrom P., et al. Tumor associated macrophages in human prostate cancer Relation to clinicopathological variables and survival. Int J Oncol. 17:2000;445-451
41. Yu J.L., Rak J.W. Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res. 5:2003;83-88
42. Leek R.D., Talks K.L., Pezzella F., et al. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res. 62:2002;1326-1329
43. Goede V., Brogelli L., Ziche M., et al. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer. 82:1999;765-770
44. Wheeler M.D., Ikejema K., Enomoto N., et al. Glycine A new anti-inflammatory immunonutrient. Cell Mol Life Sci. 56:1999;843-856
45. Rose M.L., Germolec D., Arteel G.E., et al. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14, 643. Chem Res Toxicol. 10:1997;1198-1204
46. Rose M.L., Madren J., Bunzendahl H., et al. Dietary glycine inhibits the growth of B16 melanoma tumors in mice. Carcinogenesis. 20:1999;793-798
47. Wheeler M.D., Thurman R.G. Production of superoxide and TNF-alpha from alveolar macrophages is blunted by glycine. Am J Physiol. 277:1999;L952-L959
48. Amin K., Li J., Chao W.R., et al. Dietary glycine inhibits angiogenesis during wound healing and tumor growth. Cancer Biol Ther. 2:2003;173-178
49. Folkman J. Angiogenesis inhibitors generated by tumors. Mol Med. 1:1995;120-122
50. Kirsch M., Schackert G., Black P.M. Angiogenesis, metastasis, and endogenous inhibition. J Neurooncol. 50:2000;173-180